Screening of primary immunodeficiency in patients with recurrent chest infection Prevalence, Clinical Characteristics, and Predictors of Primary Immunodeficiency in Patients with Recurrent Chest Infections Running Head: primary immunodeficiency in recurrent chest infection

Imagine the human immune system as a highly trained security force, constantly patrolling the body's borders to keep out invaders like bacteria and viruses. For most people, this force works seamlessly, fending off the occasional cold or flu without much thought. However, for a small group of individuals, this security system has a fundamental flaw from birth. These are primary immunodeficiencies, inherited conditions where the body lacks specific tools needed to fight off infection. Because the immune system is so complex, these flaws can take many different forms, but one of the most common results is a body that cannot produce enough of the antibodies that act as the immune system's specific weapons against germs. When these defenses are weak, the lungs become a frequent battleground, leading to chest infections that return again and again, often causing lasting damage to the airways.

For decades, doctors have known that some people with these recurring infections might have an underlying immune defect, but the exact number of such cases among adults and older children has remained unclear. Many patients are treated for years for standard infections without ever realizing their immune system is the root cause. This gap in knowledge can lead to delayed treatment, allowing infections to cause irreversible harm to the lungs before the true problem is identified. Understanding how often these hidden immune failures occur in people with recurrent chest infections is vital, as it could change how doctors screen patients and ensure they receive the right care much sooner.

A team of researchers from several universities in Egypt set out to fill this gap by studying a large group of patients who had been admitted to hospitals with recurrent chest infections. They gathered 190 individuals, ranging from young children to adults, who suffered from frequent respiratory illnesses. The researchers defined a "recurrent" infection as having more than six respiratory infections in a year, or more than three lower respiratory tract infections annually, or infections that were severe enough to require hospitalization or intravenous antibiotics. They carefully screened every participant to see if they had a primary immunodeficiency, ruling out other causes like heart disease, diabetes, or lung abnormalities that could explain the infections. The team performed a thorough battery of tests, including blood work to measure immune proteins, imaging of the chest, and cultures to identify the specific germs causing the illness.

The study revealed a significant finding: primary immunodeficiency was present in 13.7 percent of the patients studied. This means that roughly one in every seven people coming to the hospital with these recurring chest infections actually had an underlying immune disorder. The most common type of defect found was an antibody deficiency, where the body fails to make enough of the proteins needed to neutralize bacteria. Specifically, the most frequent diagnosis was common variable immunodeficiency, which accounted for more than half of the cases, followed by selective IgA deficiency, a condition where the body lacks a specific type of antibody that protects mucous membranes. Other rare defects involving different parts of the immune system were also found, but the antibody issues were by far the dominant pattern.

When the researchers compared the patients with immune defects to those without, clear differences emerged in their clinical stories. The patients with primary immunodeficiency were significantly younger, with a median age at diagnosis of just under two years, compared to the older age of the group without these defects. These younger patients were also more likely to have swollen lymph nodes and infections that spread beyond the lungs to other parts of the body, such as the brain, skin, or digestive tract. In contrast, the researchers found no significant difference between the two groups regarding the specific bacteria or viruses causing the infections, nor was there a difference in family history or parental relationships. This suggests that while family history is important, the absence of a known family link does not rule out an immune defect.

The laboratory results provided further clues. Patients with primary immunodeficiency had significantly lower levels of the key immune proteins IgA, IgG, and IgM in their blood. They also tended to have lower hemoglobin levels and lower white blood cell counts, likely reflecting the strain of chronic infection on their bodies. Interestingly, the type of infection seen on chest scans, such as pneumonia or bronchiectasis, did not differ significantly between the two groups, meaning the images alone could not reliably distinguish an immune defect from a standard infection. However, the presence of swollen lymph nodes and a history of infections in multiple body systems stood out as strong warning signs.

The researchers also looked at how the patients fared during their hospital stays. They found that the duration of the infection, the need for intensive care, and the requirement for mechanical ventilation were similar for both groups. This indicates that while the underlying cause was different, the immediate severity of the lung infection at the time of admission was comparable. The study concluded that primary immunodeficiency is a substantial and often overlooked cause of recurrent chest infections, particularly in children and young adults. The findings suggest that doctors should maintain a high level of suspicion for these conditions when they see younger patients with recurrent infections, swollen lymph nodes, or infections that spread to other organs, even if there is no family history of immune problems. Early recognition through simple blood tests could lead to timely treatment, potentially preventing the long-term lung damage that often accompanies these undiagnosed conditions.